ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,423.96
0.13%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Orgenesis Inc (ORGS)

  7. Orgenesis Inc (ORGS) News

Orgenesis (ORGS)

Orgenesis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORGS
DateTimeSourceHeadlineSymbolCompany
06/06/202421:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ORGSOrgenesis Inc
04/06/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ORGSOrgenesis Inc
31/05/202411:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
24/05/202414:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:ORGSOrgenesis Inc
23/05/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
21/05/202412:00GlobeNewswire Inc.Orgenesis Provides Business Update for the First Quarter of 2024NASDAQ:ORGSOrgenesis Inc
20/05/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGSOrgenesis Inc
15/05/202421:01Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ORGSOrgenesis Inc
06/05/202420:30Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ORGSOrgenesis Inc
06/05/202420:28Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ORGSOrgenesis Inc
06/05/202420:26Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ORGSOrgenesis Inc
15/04/202422:07GlobeNewswire Inc.Orgenesis Provides Year End Business UpdateNASDAQ:ORGSOrgenesis Inc
10/04/202417:00GlobeNewswire Inc.Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global AccessibilityNASDAQ:ORGSOrgenesis Inc
18/03/202412:30GlobeNewswire Inc.Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe ConferenceNASDAQ:ORGSOrgenesis Inc
13/03/202412:30GlobeNewswire Inc.Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic ExosomesNASDAQ:ORGSOrgenesis Inc
04/03/202413:30GlobeNewswire Inc.Orgenesis Inc. Announces $2.3 Million Private PlacementNASDAQ:ORGSOrgenesis Inc
29/02/202413:30GlobeNewswire Inc.Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP ManufacturingNASDAQ:ORGSOrgenesis Inc
31/01/202414:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
31/01/202414:15GlobeNewswire Inc.Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to ClinicNASDAQ:ORGSOrgenesis Inc
24/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
22/01/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
08/01/202422:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGSOrgenesis Inc
08/01/202422:36Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ORGSOrgenesis Inc
05/01/202411:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
14/11/202313:30GlobeNewswire Inc.Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TMNASDAQ:ORGSOrgenesis Inc
13/11/202321:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGSOrgenesis Inc
13/11/202321:15GlobeNewswire Inc.Orgenesis Provides Business Update for the Third Quarter of 2023NASDAQ:ORGSOrgenesis Inc
09/11/202312:41Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ORGSOrgenesis Inc
08/11/202314:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
08/11/202314:00GlobeNewswire Inc.Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct OfferingNASDAQ:ORGSOrgenesis Inc
 Showing the most relevant articles for your search:NASDAQ:ORGS

Your Recent History

NASDAQ
VERX
Vertex
LATK
SPAUSDT
Sperax
BIT
UC1GXK
Unicredit Bank
EU
D947S
D947S
BOV
W1AB34R
Wabtec
UNSW3
SNAILETH
SnailBrook
USOTC
CUGCY
China Oriental (PK)
NASDAQ
BOMN
Boston Omaha
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved